Literature DB >> 15151623

High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection.

Kazuyuki Ohata1, Keisuke Hamasaki, Kan Toriyama, Hiroki Ishikawa, Kazuhiko Nakao, Katsumi Eguchi.   

Abstract

BACKGROUND AND AIMS: Hepatitis B virus (HBV) is considered a major risk factor for the progression to liver cirrhosis and hepatocellular carcinoma (HCC). The serum level of HBV-DNA is correlated with progression of the disease. The aim of the present study was to determine the relationship between the level of HBV-DNA and hepatocarcinogenesis in patients with chronic HBV infection.
METHODS: The authors studied 73 patients who were diagnosed with chronic HBV infection at Nagasaki University Hospital (Nagasaki, Japan) between January 1980 and December 1999. The significance of age, sex, habitual drinking, serum alanine aminotransferase level, HBV viral load, interferon treatment, hepatic fibrosis and hepatic inflammation on the development of HCC were examined using univariate and multivariate analyses.
RESULTS: The cumulative incidence rates of HCC were 14%, 29% and 48% at 5, 10 and 15 years after liver biopsy, respectively. Multivariate analysis identified high viral load, together with age and severe fibrosis, as independent and significant risk factors (P = 0.045, 0.047 and 0.013, respectively) for HCC.
CONCLUSIONS: The present findings indicate that high viral load is a risk factor for HCC in patients with chronic HBV infection. Patients with a high HBV viral load should be carefully monitored for HCC.

Entities:  

Mesh:

Year:  2004        PMID: 15151623     DOI: 10.1111/j.1440-1746.2004.03360.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  31 in total

1.  Family history of liver cancer may modify the association between HBV infection and liver cancer in a Chinese population.

Authors:  Xing Liu; Aileen Baecker; Ming Wu; Jin-Yi Zhou; Jie Yang; Ren-Qiang Han; Pei-Hua Wang; Zi-Yi Jin; Ai-Min Liu; Xiaoping Gu; Xiao-Feng Zhang; Xu-Shan Wang; Ming Su; Xu Hu; Zheng Sun; Gang Li; Alan Fu; Su Yon Jung; Lina Mu; Na He; Liming Li; Jin-Kou Zhao; Zuo-Feng Zhang
Journal:  Liver Int       Date:  2019-07-10       Impact factor: 5.828

2.  Clinical analysis of the risk factors for recurrence of HCC and its relationship with HBV.

Authors:  Di-Peng Ou; Lian-Yue Yang; Geng-Wen Huang; Yi-Ming Tao; Xiang Ding; Zhi-Gang Chang
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

3.  He Jie Tang in the treatment of chronic hepatitis B patients.

Authors:  Ze-Xiong Chen; Shi-Jun Zhang; Shao-Xian Lao; Hong-Tao Hu; Cui-Yi Zhang; Shi-He Guan; Yan-Li Gu
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

4.  Hepatocellular carcinoma in Egypt: a single center study over a decade.

Authors:  Abdel-Rahman el-Zayadi; Hanaa M Badran; Eman M F Barakat; Mohy el-Deen Attia; Sherine Shawky; Mostafa K Mohamed; Osaima Selim; Ahmed Saeid
Journal:  World J Gastroenterol       Date:  2005-09-07       Impact factor: 5.742

5.  Screening for hepatocellular carcinoma by Egyptian physicians.

Authors:  Sahar M Hassany; Ehab F Abdou Moustafa; Mohamed El Taher; Afaf Adel Abdeltwab; Hubert E Blum
Journal:  World J Gastrointest Oncol       Date:  2015-09-15

6.  Human Schistosomiasis mansoni associated with hepatocellular carcinoma in Egypt: current perspective.

Authors:  Manar Mahmoud El-Tonsy; Hesham Mohammed Hussein; Thanaa El-Sayed Helal; Rania Ayman Tawfik; Khalid Mohamed Koriem; Hend Mohamed Hussein
Journal:  J Parasit Dis       Date:  2014-12-20

7.  Baseline prognostic factors and statistic model to predict early virological response in lamivudine-treated patients with chronic hepatitis B.

Authors:  Rui Zhou; Fan Pan; Chun Lin; Xiuquan Lin; Haibing Gao; Shuiwen Huang; Zuxiong Huang; Yong Lin; Chen Pan; Yuanping Zhou
Journal:  Int J Clin Exp Med       Date:  2015-10-15

8.  A case-control study of the relationship between hepatitis B virus DNA level and risk of hepatocellular carcinoma in Qidong, China.

Authors:  Tao-Tao Liu; Ying Fang; Hui Xiong; Tao-Yang Chen; Zheng-Pin Ni; Jian-Feng Luo; Nai-Qing Zhao; Xi-Zhong Shen
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

9.  HBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: a prospective study.

Authors:  Zhong-Liao Fang; Caroline A Sabin; Bai-Qing Dong; Lian-Ying Ge; Shao-Chao Wei; Qin-Yan Chen; Kong-Xiong Fang; Jin-Ye Yang; Xue-Yan Wang; Tim J Harrison
Journal:  Am J Gastroenterol       Date:  2008-09       Impact factor: 10.864

10.  Hepatoprotective effects of the nitric oxide donor isosorbide-5-mononitrate alone and in combination with the natural hepatoprotectant, silymarin, on carbon tetrachloride-induced hepatic injury in rats.

Authors:  Omar Mohamed E Abdel Salam; Amany A Sleem; Nermeen Shafee
Journal:  Inflammopharmacology       Date:  2010-01-14       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.